ERNA vs PODD · P/E 0.0, rev $582.0K vs P/E 34, rev $2.07B
Eterna Therapeutics Inc (ERNA) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the ERNA and PODD stock pages for the full models.
Not investment advice.